Table 2.

Unfavorable Prognostic Factors in JMML

FeatureStudy (reference)FeatureStudy (reference)
Age (mo)  HBF level 
>48 Niemeyer19  Increased Castro15  
>24 Castro,15 Passmore20   >15% Niemeyer19  
>12 Aricò,30 Pui50   >10% Owen,29 Passmore20  
>6 Owen29  Thrombocytopenia (×109/L) 
Male sex Owen29   <100 Castro15  
   <50 Aricò30  
Bleeding Castro,15 Owen29   <40 Passmore20  
 Niemeyer19   <33 Niemeyer19  
Hepatomegaly (>3 cm) Castro15  Blasts in peripheral blood 
   ≥2 × 109/L Castro15  
Hb level (<10 g/dL) Niemeyer19   >4% Niemeyer19  
Reticulocytes (<10%) Niemeyer19  Normoblasts in peripheral blood (>1 × 109/L) Castro15  
FPC score (≥2)* Passmore20  Blasts in the BM myeloid compartment (>5%) Niemeyer19  
FeatureStudy (reference)FeatureStudy (reference)
Age (mo)  HBF level 
>48 Niemeyer19  Increased Castro15  
>24 Castro,15 Passmore20   >15% Niemeyer19  
>12 Aricò,30 Pui50   >10% Owen,29 Passmore20  
>6 Owen29  Thrombocytopenia (×109/L) 
Male sex Owen29   <100 Castro15  
   <50 Aricò30  
Bleeding Castro,15 Owen29   <40 Passmore20  
 Niemeyer19   <33 Niemeyer19  
Hepatomegaly (>3 cm) Castro15  Blasts in peripheral blood 
   ≥2 × 109/L Castro15  
Hb level (<10 g/dL) Niemeyer19   >4% Niemeyer19  
Reticulocytes (<10%) Niemeyer19  Normoblasts in peripheral blood (>1 × 109/L) Castro15  
FPC score (≥2)* Passmore20  Blasts in the BM myeloid compartment (>5%) Niemeyer19  
*

Relevant in all cases of childhood MDS, including JMML.

or Create an Account

Close Modal
Close Modal